The Authors’ Reply to van Baal et al.: “Pharmacoeconomic Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al.”
Year of publication: |
2013
|
---|---|
Authors: | Grima, Daniel ; Bernard, Lisa ; Dunn, Elizabeth ; McFarlane, Philip ; Mendelssohn, David |
Published in: |
PharmacoEconomics. - Springer, ISSN 1170-7690. - Vol. 31.2013, 5, p. 375-376
|
Publisher: |
Springer |
Saved in:
Saved in favorites
Similar items by person
-
Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis
Grima, Daniel, (2012)
-
Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis
Grima, Daniel, (2012)
-
The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care
Manns, Braden, (2007)
- More ...